Treace Medical Concepts, Inc.
TMCI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6% | -9.9% | -23.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 79.1% | 79.7% | 79.7% | 80.7% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -24.2% | -28.5% | -23.1% | 4.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -32.4% | -36.7% | -30.3% | -0.7% |
| EPS Diluted | -0.26 | -0.28 | -0.25 | -0.008 |
| % Growth | 7.1% | -12% | -3,025% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |